Perspective Therapeutics (CATX) Total Current Liabilities (2011 - 2026)

Perspective Therapeutics has reported Total Current Liabilities for 16 years, with the latest figure at $31.5 million in Q1 2026.

• Quarterly Total Current Liabilities rose 148.33% year-over-year to $31.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31.5 million (up 148.33% YoY) and the FY2025 annual result came in at $28.7 million, up 57.32% from the prior year.
• Total Current Liabilities climbed to $31.5 million in Q1 2026 per CATX's latest filing, from $28.7 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $31.5 million in Q1 2026 and troughed at $2.0 million in Q1 2022.
• A 5-year average of $13.5 million and a median of $12.7 million in 2025 frame the typical range for Total Current Liabilities.
• The sharpest annual moves came in 2023 and 2025: Total Current Liabilities surged 402.37% in 2023, then decreased 26.74% in 2025.
• Over 5 years, Total Current Liabilities stood at $3.1 million in 2022, then soared by 402.37% to $15.7 million in 2023, then advanced by 16.38% to $18.2 million in 2024, then jumped by 57.32% to $28.7 million in 2025, then climbed by 9.79% to $31.5 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $31.5 million, $28.7 million, and $20.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.